The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Competent psychopharmacology.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesUse of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program.Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring
P2860
The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of regulatory advis ...... study of 228,876 pregnancies.
@en
The effect of regulatory advis ...... study of 228,876 pregnancies.
@nl
type
label
The effect of regulatory advis ...... study of 228,876 pregnancies.
@en
The effect of regulatory advis ...... study of 228,876 pregnancies.
@nl
prefLabel
The effect of regulatory advis ...... study of 228,876 pregnancies.
@en
The effect of regulatory advis ...... study of 228,876 pregnancies.
@nl
P2093
P2860
P1476
The effect of regulatory advis ...... study of 228,876 pregnancies.
@en
P2093
Ed Mitchel
Jeff Horner
Pingsheng Wu
Rachel M Hayes
Richard A Epstein
Richard C Shelton
Tina V Hartert
William V Bobo
P2860
P2888
P356
10.1007/S00737-013-0383-6
P577
2013-10-03T00:00:00Z